These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2413402)

  • 1. Dopaminergic toxicity after the stereotaxic administration of the 1-methyl-4-phenylpyridinium ion (MPP+) to rats.
    Heikkila RE; Nicklas WJ; Duvoisin RC
    Neurosci Lett; 1985 Aug; 59(1):135-40. PubMed ID: 2413402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H
    Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
    Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
    Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
    Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL; Yong VW; Jones K; Wall RA; Clavier RM; Foulks JG; Wright JM
    Neurosci Lett; 1985 Aug; 58(3):321-6. PubMed ID: 3876525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
    Ozaki N; Nakahara D; Kaneda N; Kiuchi K; Okada T; Kasahara Y; Nagatsu T
    J Neural Transm; 1987; 70(3-4):241-50. PubMed ID: 3500274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    Neuropharmacology; 1984 Jun; 23(6):711-3. PubMed ID: 6611514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MPP+ on the release of serotonin and 5-hydroxyindoleacetic acid from rat striatum in vivo.
    Miyake H; Chiueh CC
    Eur J Pharmacol; 1989 Jul; 166(1):49-55. PubMed ID: 2478372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
    Bonuccelli U; Garant D; Fariello R
    Neurosci Lett; 1991 Mar; 124(1):22-6. PubMed ID: 1713316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Chang GD; Ramirez VD
    Brain Res; 1986 Mar; 368(1):134-40. PubMed ID: 3485463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplacentally-transported 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects the catecholamine and indoleamine levels in the fetal mouse brain.
    Ohya Y; Naoi M; Ochi N; Mizutani N; Watanabe K; Nagatsu T
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):277-83. PubMed ID: 1706600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium.
    Giovanni A; Sonsalla PK; Heikkila RE
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1008-14. PubMed ID: 7932148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
    Bradbury AJ; Costall B; Jenner PG; Kelly ME; Marsden CD; Naylor RJ
    Neurosci Lett; 1985 Jul; 58(2):177-81. PubMed ID: 2413398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
    Pileblad E; Nissbrandt H; Carlsson A
    J Neural Transm; 1984; 60(3-4):199-203. PubMed ID: 6084705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.